838
Views
0
CrossRef citations to date
0
Altmetric
FERTILITY PRESERVATION

Fertility preservation in ovarian cancer patients

ORCID Icon, ORCID Icon & ORCID Icon
Pages 483-489 | Received 23 Apr 2020, Accepted 04 Jan 2021, Published online: 27 Jan 2021

References

  • American Cancer Society. Ovarian cancer. https://www.cancer.org/content/dam/CRC/PDF/Public/8773.00.pdf.
  • Kim S-Y, Lee JR. Fertility preservation option in young women with ovarian cancer. Future Oncol. 2016;12(14):1695–1698.
  • American Cancer Society. Ovarian cancer - treatment. https://www.cancer.org/cancer/ovarian-cancer/treating/by-stage.html.
  • Cakmak H, Rosen MP. Random-start ovarian stimulation in patients with cancer. Curr Opin Obstet Gynecol. 2015;27(3):215–221.
  • Mahajan N. Fertility preservation in female cancer patients: an overview. J Hum Reprod Sci. 2015;8(1):3–13.
  • Santos TA, Silva C. 2015. Oncofertilidade – Preservação Da Fertilidade Em Doentes Oncológicos. Lisbon: LST Artes gráficas.
  • Practice Committee of the American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112:1022–1033.
  • McKenzie ND, Kennard JA, Ahmad S. Fertility preserving options for gynecologic malignancies: a review of current understanding and future directions. Crit Rev Oncol Hematol. 2018;132:116–124.
  • Donnez J, Dolmans M-M. Fertility preservation in women. N Engl J Med. 2017;377(17):1657–1665.
  • Senra JC, Roque M, Talim MCT, et al. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(1):77–86.
  • Taylan E, Oktay K. Fertility preservation in gynecologic cancers. Gynecol Oncol. 2019;155(3):522–529.
  • Medrano JV, Andrés MDM, García S, et al. Basic and clinical approaches for fertility preservation and restoration in cancer patients. Trends Biotechnol. 2018;36(2):199–215.
  • Lawrenz B, Mahajan N, Fatemi HM. The effects of cancer therapy on women’s fertility: what do we know now? Future Oncol. 2016;12(14):1721–1729.
  • Lambertini M, Horicks F, Del Mastro L, et al. Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: from biological evidence to clinical application. Cancer Treat Rev. 2019;72:65–77.
  • Lucas K, Hensel D. Fertility preservation options for women treated for cancer. Nurs Womens Health. 2014;18(2):138–147.
  • Chan JL, Wang ET. Oncofertility for women with gynecologic malignancies. Gynecol Oncol. 2017;144(3):631–636.
  • Harada M, Osuga Y. Where are oncofertility and fertility preservation treatments heading in 2016? Future Oncol. 2016;12(20):2313–2321.
  • Trudgen K, Ayensu-Coker L. Fertility preservation and reproductive health in the pediatric, adolescent, and young adult female cancer patient. Curr Opin Obstetr Gynecol. 2014;26:372–380.
  • Wallace WHB, Kelsey TW, Anderson RA. Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation. Fertil Steril. 2016;105(1):6–12.
  • Casorelli A, Panici PB, Palaia I, et al. Fertility management for malignant ovarian germ cell tumors patients. Crit Rev Oncol Hematol. 2017;120:34–42.
  • Silva C, Caramelo O, Almeida-Santos T, et al. Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2737–2749.
  • Fisch B, Abir R. Female fertility preservation: past, present and future. Reproduction. 2018;156(1):F11–27.
  • Pinelli S, Basile S. Fertility preservation: current and future perspectives for oncologic patients at risk for iatrogenic premature ovarian insufficiency. Biomed Res Int. 2018;2018:6465903–6465909.
  • Kim S, Lee Y, Lee S, et al. Ovarian tissue cryopreservation and transplantation in patients with cancer. Obstet Gynecol Sci. 2018;61(4):431–442.
  • Dolmans MM. Recent advances in fertility preservation and counseling for female cancer patients. Expert Rev Anticancer Ther. 2018;18(2):115–120.
  • Hickman LC, Valentine LN, Falcone T. Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists. Am J Obstet Gynecol. 2016;215(4):415–422.
  • Raffoul L, Capito C, Sarnacki S. Fertility considerations and the pediatric oncology patient. Semin Pediatr Surg. 2016;25(5):318–322.
  • Del Mastro L, Lambertini M. Temporary ovarian suppression with gonadotropin-releasing hormone agonist during chemotherapy for fertility preservation: toward the end of the debate? Oncologist. 2015;20(11):1233–1235.
  • Lambertini M, Ginsburg ES, Partridge AH. Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy. Curr Opin Obstet Gynecol. 2015;27(1):98–107.
  • Jang H, Hong K, Choi Y. Melatonin and fertoprotective adjuvants: prevention against premature ovarian failure during chemotherapy. IJMS. 2017;18(6):1221.
  • Donnez J, Dolmans MM. Ovarian tissue freezing: current status. Curr Opin Obstet Gynecol. 2015;27(3):222–230.
  • Ross L, Chung K, Macdonald H. Fertility preservation in the female cancer patient. J Surg Oncol. 2014;110(8):907–911.
  • Peccatori F, Pup L. d, Tomao F, et al. Special issues in fertility preservation for gynecologic malignancies. Crit Rev Oncol Hematol. 2016;97:206–219.
  • Letourneau J, Chan J, Salem W, et al. Fertility sparing surgery for localized ovarian cancers maintains an ability to conceive, but is associated with diminished reproductive potential. J Surg Oncol. 2015;112(1):26–30.
  • Ghalleb M, Bouzaiene H, Slim S, et al. Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report. J Med Case Reports. 2017;11(1):10–12.
  • Ghalleb M, Bouzaiene H, Sghaier S, et al. Fertility sparing surgery for ovarian sex cord stromal tumors: a nine case series. Pan Afr Med J. 2018;31:221–226.
  • Crafton SM, Cohn DE, Llamocca EN, et al. Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries. Cancer. 2020;126(6):1217–1224.
  • Yoshihara M, Kajiyama H, Tamauchi S, et al. Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis. J Gynecol Oncol. 2019;30(6):e102.
  • Balachandren N, Davies M. Fertility, ovarian reserve and cancer. Maturitas. 2017;105:64–68.
  • Johansen MS, Tanbo TG, Oldereid NB. Fertility after cryopreservation of ovarian tissue due to cancer treatment. Tidsskr Nor Laegeforen. 2018;138.
  • Ciotti P, Moscarini M, Paradisi R, et al. Healthy twins delivered after oocyte cryopreservation and bilateral ovariectomy for ovarian cancer. Reprod BioMed Online. 2008;17(2):265–267.
  • Alvarez M, Solé M, Devesa M, et al. Live birth using vitrified-warmed oocytes in invasive ovarian cancer: case report and literature review. Reprod Biomed Online. 2014;28(6):663–668.
  • Levine JM, Kelvin JF, Quinn GP, et al. Infertility in reproductive-age female cancer survivors. Cancer. 2015;121(10):1532–1539.
  • Whyte JS, Hawkins E, Rausch M, et al. In vivo oocyte retrieval in a young woman with ovarian cancer. Obstetr Gynecol. 2014;124:484–486.
  • Kim S-Y, Kim SK, Lee JR, et al. Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women. J Gynecol Oncol. 2016;27(2):e22.
  • Henes M, Neis F, Krämer B, et al. Possibilities of fertility preservation in young patients with ovarian cancer. Anticancer Res. 2014;34(7):3851–3854.
  • Grynberg M, Raad J, Comtet M, et al. Fertility preservation in BRCA-mutated women: when and how? Future Oncol. 2018;14(5):483–490.
  • Lambertini M, Goldrat O, Ferreira AR, et al. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients. Ann Oncol. 2018;29(1):237–243.
  • Dolmans MM, Marotta ML, Pirard C, et al. Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes. J Ovarian Res. 2014;7:80–86.
  • Fatemi HM, Kyrou D, Al-Azemi M, et al. Ex-vivo oocyte retrieval for fertility preservation. Fertil Steril. 2011;95(5):1787.e15–1787.e17.
  • Perez de la Blanca E, Fernandez-Perez MF, del Mar Martin-Diaz E, et al. Ultrasound-guided ex-vivo retrieval of mature oocytes for fertility preservation during laparoscopic oophorectomy: a case report. J Reprod Infert. 2018;19:174–181.
  • Park CW, Lee SH, Yang KM, et al. Cryopreservation of in vitro matured oocytes after ex vivo oocyte retrieval from gynecologic cancer patients undergoing radical surgery. Clin Exp Reprod Med. 2016;43(2):119–125.
  • Komlichenko E, Kalinina E, Gamzatova Z, et al. Autotransplantation of cryopreserved ovarian tissue – effective method of fertility preservation in cancer patients. Gynecol Endocrinol. 2014;30(sup1):43–47.
  • Fajau-Prevot C, Le Gac YT, Chevreau C, et al. Ovarian mucinous cystadenoma after ovarian graft. Obstet Gynecol. 2017;129(6):1035–1036.
  • Duros S, Vinolas C, Comtet M, et al. Fertility preservation in women. Med Ther Med Reprod Gynecol Endocrinol. 2018;20:4–10.
  • Son W-Y, Buckett W, Monnier P, et al. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment. Fertil Steril. 2017;107(1):198–204. Elsevier Inc.
  • Rodriguez-Wallberg K, Turan V, Munster P, et al. Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients? Ann Oncol. 2016;27(2):357.
  • Blumenfeld Z, Katz G, Evron A. ‘An ounce of prevention is worth a pound of cure’: the case for and against GnRH-agonist for fertility preservation”: . Ann Oncol. 2014;25(9):1719–1728.
  • Roness H, Kalich-Philosoph L, Meirow D. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents. Hum Reprod Update. 2014;20(5):759–774.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.